Aspen Aerogels Analyst Ratings
Analysts Offer Insights on Industrial Goods Companies: Terran Orbital Corp (LLAP), Bluelinx Holdings (BXC) and Aspen Aerogels (ASPN)
Truist Securities Adjusts Price Target on Insmed to $68 From $48 After Positive ASPEN Results, Maintains Buy Rating
Insmed's Promising Future: A Buy Rating With Increased Price Target Post-ASPEN Trial Success
Buy Rating on Insmed With Increased Price Target Following Successful Phase 3 ASPEN Study of Brensocatib
PhillipCapital Adjusts LHN's Price Target to SG$0.42 From SG$0.39, Keeps at Buy
CLSA Upgrades City Developments to Accumulate From Reduce; Price Target Is SG$6.41
Aspen Technology Analyst Ratings
Berenberg Upgrades Aspen Technology to Buy From Hold, Raises Price Target to $255 From $185, Says Overhangs Have Been Removed
Aspen Technology Analyst Ratings
Aspen Aerogels Analyst Ratings
Buy Rating Affirmed for Insmed on Strong TPIP Trial Results and High Anticipation for ASPEN Trial Outcomes
Baird Adjusts Price Target on Aspen Technology to $210 From $225, Keeps Outperform Rating
Piper Sandler Cuts Price Target on Aspen Technology to $180 From $196, Keeps Neutral Rating
Piper Sandler Adjusts Price Target on Aspen Technology to $180 From $196, Maintains Neutral Rating
Baird Maintains Outperform on Aspen Technology, Lowers Price Target to $210
Aspen Technology Analyst Ratings
Analysts Offer Insights on Technology Companies: Aspen Technology, Inc. (AZPN), Arista Networks (ANET) and Cirrus Logic (CRUS)
Aspen Technology, Inc. (AZPN) Gets a Hold From William Blair
Aspen Aerogels Analyst Ratings